CN Patent

CN111658642A — 一种治疗耐碳青霉烯类抗生素鲍曼不动杆菌感染的组合物

Assigned to Guangzhou Xinchuangyi Medicine Clinical Research Co ltd · Expires 2020-09-15 · 6y expired

What this patent protects

本发明公开了一种治疗耐碳青霉烯类抗生素鲍曼不动杆菌感染的组合物。发明人研究发现，使用特定比例的舒巴坦头孢他啶的组合，对CR‑Ab感染具有优异的治疗效果，其治疗效果甚至强于碳青霉烯和舒巴坦的组合物。

USPTO Abstract

本发明公开了一种治疗耐碳青霉烯类抗生素鲍曼不动杆菌感染的组合物。发明人研究发现，使用特定比例的舒巴坦头孢他啶的组合，对CR‑Ab感染具有优异的治疗效果，其治疗效果甚至强于碳青霉烯和舒巴坦的组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN111658642A
Jurisdiction
CN
Classification
—
Expires
2020-09-15
Drug substance claim
No
Drug product claim
No
Assignee
Guangzhou Xinchuangyi Medicine Clinical Research Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.